Skip to Content

GS TEW 50 mg (Tafinlar 50 mg)

Generic Name: dabrafenib

Pill with imprint GS TEW 50 mg is Red, Capsule-shape and has been identified as Tafinlar 50 mg. It is supplied by GlaxoSmithKline.

Tafinlar is used in the treatment of melanoma, metastatic and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GS TEW 50 mg

Tafinlar

Generic Name:
dabrafenib
Imprint:
GS TEW 50 mg
Strength:
50 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
National Drug Code (NDC):
00173-0846

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide